Ajanta Pharma Limited (AJANTPHARM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.066x

Based on the latest financial reports, Ajanta Pharma Limited (AJANTPHARM) has a cash flow conversion efficiency ratio of 0.066x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs2.84 Billion ≈ $30.71 Million USD) by net assets (Rs43.15 Billion ≈ $466.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see AJANTPHARM market cap for the company's overall valuation and market capitalisation.

Ajanta Pharma Limited - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how Ajanta Pharma Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Ajanta Pharma Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Ajanta Pharma Limited ranked by their cash flow conversion efficiency. Explore Ajanta Pharma Limited (AJANTPHARM) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Crocs Inc
NASDAQ:CROX
-0.037x
Celanese Corporation
NYSE:CE
0.062x
Fujian Wanchen Biotechnology Co. Ltd
SHE:300972
N/A
Nexstar Broadcasting Group Inc
NASDAQ:NXST
0.133x
SIG Combibloc Group AG
SW:SIGN
0.185x
Guangzhou Shiyuan Electronic Technology Co Ltd
SHE:002841
-0.024x
TAL Education Group
NYSE:TAL
0.117x
KEI Industries Limited
NSE:KEI
0.062x

Annual Cash Flow Conversion Efficiency for Ajanta Pharma Limited (2005–2025)

The table below shows the annual cash flow conversion efficiency of Ajanta Pharma Limited from 2005 to 2025. View AJANTPHARM stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs37.90 Billion
≈ $409.91 Million
Rs11.57 Billion
≈ $125.15 Million
0.305x +38.73%
2024-03-31 Rs35.67 Billion
≈ $385.80 Million
Rs7.85 Billion
≈ $84.90 Million
0.220x -5.83%
2023-03-31 Rs33.88 Billion
≈ $366.40 Million
Rs7.92 Billion
≈ $85.63 Million
0.234x +35.73%
2022-03-31 Rs32.64 Billion
≈ $353.03 Million
Rs5.62 Billion
≈ $60.78 Million
0.172x -10.50%
2021-03-31 Rs29.96 Billion
≈ $323.97 Million
Rs5.76 Billion
≈ $62.33 Million
0.192x +9.46%
2020-03-31 Rs25.99 Billion
≈ $281.06 Million
Rs4.57 Billion
≈ $49.40 Million
0.176x +5.29%
2019-03-31 Rs22.45 Billion
≈ $242.81 Million
Rs3.75 Billion
≈ $40.53 Million
0.167x +19.39%
2018-03-31 Rs20.41 Billion
≈ $220.77 Million
Rs2.85 Billion
≈ $30.87 Million
0.140x -63.95%
2017-03-31 Rs15.68 Billion
≈ $169.54 Million
Rs6.08 Billion
≈ $65.76 Million
0.388x +39.29%
2016-03-31 Rs11.72 Billion
≈ $126.75 Million
Rs3.26 Billion
≈ $35.30 Million
0.278x -16.18%
2015-03-31 Rs8.41 Billion
≈ $90.96 Million
Rs2.79 Billion
≈ $30.22 Million
0.332x -7.21%
2014-03-31 Rs5.93 Billion
≈ $64.16 Million
Rs2.12 Billion
≈ $22.97 Million
0.358x -40.32%
2013-03-31 Rs3.93 Billion
≈ $42.51 Million
Rs2.36 Billion
≈ $25.50 Million
0.600x +133.59%
2012-03-31 Rs2.98 Billion
≈ $32.23 Million
Rs765.41 Million
≈ $8.28 Million
0.257x -41.57%
2011-03-31 Rs2.29 Billion
≈ $24.75 Million
Rs1.01 Billion
≈ $10.88 Million
0.440x -14.54%
2010-03-31 Rs1.85 Billion
≈ $20.00 Million
Rs951.16 Million
≈ $10.29 Million
0.514x +133.60%
2009-03-31 Rs1.57 Billion
≈ $16.99 Million
Rs345.92 Million
≈ $3.74 Million
0.220x +55.96%
2008-03-31 Rs1.35 Billion
≈ $14.62 Million
Rs190.81 Million
≈ $2.06 Million
0.141x -22.80%
2007-03-31 Rs1.16 Billion
≈ $12.50 Million
Rs211.30 Million
≈ $2.29 Million
0.183x -21.67%
2006-03-31 Rs1.09 Billion
≈ $11.74 Million
Rs253.45 Million
≈ $2.74 Million
0.233x +446.42%
2005-03-31 Rs978.24 Million
≈ $10.58 Million
Rs-65.93 Million
≈ $-713.01K
-0.067x --

About Ajanta Pharma Limited

NSE:AJANTPHARM India Drug Manufacturers - Specialty & Generic
Market Cap
$4.81 Billion
Rs445.22 Billion INR
Market Cap Rank
#3663 Global
#161 in India
Share Price
Rs3563.60
Change (1 day)
+1.80%
52-Week Range
Rs2388.40 - Rs3718.20
All Time High
Rs3718.20
About

Ajanta Pharma Limited, together with its subsidiaries, a pharmaceutical formulation company that develops, manufactures, and markets specialty pharmaceutical finished dosages. The company offers chronic and acute therapies; branded generic products; and a range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. It also serves various therapeutic a… Read more